These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32104742)

  • 1. Antifungal susceptibility pattern and biofilm-related genes expression in planktonic and biofilm cells of
    Modiri M; Hashemi SJ; GhazvinI RD; Khodavaisy S; Ahmadi A; Ghaffari M; Rezaie S
    Curr Med Mycol; 2019; 5(4):35-42. PubMed ID: 32104742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: Species distribution, antifungal susceptibility and virulence attributes.
    Ziccardi M; Souza LO; Gandra RM; Galdino AC; Baptista AR; Nunes AP; Ribeiro MA; Branquinha MH; Santos AL
    Int J Med Microbiol; 2015 Dec; 305(8):848-59. PubMed ID: 26319940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal susceptibility and virulence of Candida parapsilosis species complex: an overview of their pathogenic potential.
    Brilhante RSN; Sales JA; da Silva MLQ; de Oliveira JS; Pereira LA; Pereira-Neto WA; Cordeiro RA; Sidrim JJC; Castelo-Branco DSCM; Rocha MFG
    J Med Microbiol; 2018 Jul; 67(7):903-914. PubMed ID: 29846153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virulence factors, antifungal susceptibility and molecular mechanisms of azole resistance among Candida parapsilosis complex isolates recovered from clinical specimens.
    Neji S; Hadrich I; Trabelsi H; Abbes S; Cheikhrouhou F; Sellami H; Makni F; Ayadi A
    J Biomed Sci; 2017 Sep; 24(1):67. PubMed ID: 28870262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species Distribution, Virulence Factors, and Antifungal Susceptibility Among Candida parapsilosis Complex Isolates Recovered from Clinical Specimens.
    da Silva BV; Silva LB; de Oliveira DB; da Silva PR; Ferreira-Paim K; Andrade-Silva LE; Silva-Vergara ML; Andrade AA
    Mycopathologia; 2015 Dec; 180(5-6):333-43. PubMed ID: 26138435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
    Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G
    J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activities of seven antifungal drugs against clinical isolates of Candida parapsilosis complex.
    Khodavaisy S; Badali H; Meis JF; Modiri M; Mahmoudi S; Abtahi H; Salehi M; Dehghan Manshadi SA; Aala F; Agha Kuchak Afshari S; Lotfali E; Ahangarkani F; Rezaie S
    J Mycol Med; 2020 Sep; 30(3):100968. PubMed ID: 32386800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex.
    Cordeiro RA; Macedo RB; Teixeira CEC; Marques FJF; Bandeira TJPG; Moreira JLB; Brilhante RSN; Rocha MFG; Sidrim JJC
    J Med Microbiol; 2014 Jul; 63(Pt 7):936-944. PubMed ID: 24722799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidemia by species of the Candida parapsilosis complex in children's hospital: prevalence, biofilm production and antifungal susceptibility.
    Ruiz LS; Khouri S; Hahn RC; da Silva EG; de Oliveira VK; Gandra RF; Paula CR
    Mycopathologia; 2013 Apr; 175(3-4):231-9. PubMed ID: 23404576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of the Effect of Farnesol on Biofilm Formation by Candida albicans and Candida parapsilosis Complex Isolates].
    Erdal B; Baylan B; Batar B; Öztürk A; Topçu B
    Mikrobiyol Bul; 2024 Jan; 58(1):49-62. PubMed ID: 38263940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan.
    Chen YC; Lin YH; Chen KW; Lii J; Teng HJ; Li SY
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):284-92. PubMed ID: 20851551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal susceptibility and virulence attributes of animal-derived isolates of Candida parapsilosis complex.
    Brilhante RSN; Rodrigues TJS; Castelo-Branco DSCM; Teixeira CEC; Macedo RB; Bandeira SP; Pereira de Alencar L; Monteiro AJ; Cordeiro RA; Bandeira TJPG; Moreira JLB; Sidrim JJC; Rocha MFG
    J Med Microbiol; 2014 Nov; 63(Pt 11):1568-1572. PubMed ID: 25190736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular identification and antifungal susceptibility profiles of Candida parapsilosis complex species isolated from culture collection of clinical samples.
    Ataides FS; Costa CR; Souza LK; Fernandes Od; Jesuino RS; Silva Mdo R
    Rev Soc Bras Med Trop; 2015; 48(4):454-9. PubMed ID: 26312937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital.
    Silva AP; Miranda IM; Lisboa C; Pina-Vaz C; Rodrigues AG
    J Clin Microbiol; 2009 Aug; 47(8):2392-7. PubMed ID: 19494078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency, virulence factors and antifungal susceptibility of Candida parapsilosis species complex isolated from patients with candidemia in the central region of Argentina.
    Vigezzi C; Icely PA; Dudiuk C; Rodríguez E; Miró MS; Castillo GDV; Azcurra AI; Abiega C; Caeiro JP; Riera FO; García-Effrón G; Sotomayor CE
    J Mycol Med; 2019 Dec; 29(4):285-291. PubMed ID: 31668524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis.
    Miranda-Cadena K; Marcos-Arias C; Mateo E; Aguirre JM; Quindós G; Eraso E
    Arch Oral Biol; 2018 Nov; 95():100-107. PubMed ID: 30096698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Candida parapsilosis complex isolates.
    de Toro M; Torres MJ; Maite R; Aznar J
    Clin Microbiol Infect; 2011 Mar; 17(3):418-24. PubMed ID: 20636431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species distribution and antifungal susceptibility among clinical isolates of Candida parapsilosis complex from India.
    Maria S; Barnwal G; Kumar A; Mohan K; Vinod V; Varghese A; Biswas R
    Rev Iberoam Micol; 2018; 35(3):147-150. PubMed ID: 29997030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution, virulence attributes and antifungal susceptibility patterns of Candida parapsilosis complex strains isolated from clinical samples.
    Tosun I; Akyuz Z; Guler NC; Gulmez D; Bayramoglu G; Kaklikkaya N; Arikan-Akdagli S; Aydin F
    Med Mycol; 2013 Jul; 51(5):483-92. PubMed ID: 23216051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and antifungal susceptibility of Candida parapsilosis complex isolates collected from oral cavities of HIV-infected individuals.
    Moris DV; Melhem MSC; Martins MA; Souza LR; Kacew S; Szeszs MW; Carvalho LR; Pimenta-Rodrigues MV; Berghs HAM; Mendes RP
    J Med Microbiol; 2012 Dec; 61(Pt 12):1758-1765. PubMed ID: 22956748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.